AXSOME THERAPEUTICS, INC. (AXSM) Return on equity 2022–2025
AXSOME THERAPEUTICS, INC. (AXSM) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-207.5%FY2025 · since FY2022: -170.8% → -207.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -207.5% | +296.3 pp |
| FY2024 | -503.8% | -378.5 pp |
| FY2023 | -125.3% | +45.5 pp |
| FY2022 | -170.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice